Gilead Provides Update on Phase 3 ASCENT-07 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. UNP
7. GOOGL
8. RNG
9. SPY
10. TMUS

Go back to Gilead Provides Update on Phase 3 ASCENT-07 Study
Gilead Sciences (NASDAQ: GILD) Delayed: 129.31 -1.55 (1.18%)
Previous Close $130.86    52 Week High $108.63 
Open $130.93    52 Week Low $71.39 
Day High $131.65    P/E 71.44 
Day Low $129.04    EPS $1.81 
Volume 5,529,733